ESG Alone Offers Lasting Benefits for Obesity Comorbidities

TOPLINE: Endoscopic sleeve gastroplasty (ESG) as a standalone treatment is a safe and effective minimally invasive therapy that could help achieve significant long-term weight loss and sustained improvements in obesity-related comorbidities. METHODOLOGY: Researchers conducted a 5-year prospective cohort study to evaluate the long-term effects of ESG as monotherapy on obesity-related comorbidities in 404 adult patients …
Read More